Retatrutide, a triple agonist in Phase 3 clinical trials, produced average weight loss of 24 percent at 48 weeks in Phase 2 data (Jastreboff et al., NEJM , 2023)
If youve missed several consecutive doses, contact your healthcare provider before resuming
34: 1496500 Moorthy AV, Rosenblum M, Rajaram R, et al
P.YadavR.SinghA
Regiospecificity of placental metabolism by cytochromes P450 and glutathione S-transferase
Another study done with mice by Forst and colleagues, showed that binding of GLP-1 to the GLP-1 receptor in the myocardium leads to an increase in production of cAMP and activation of protein kinase A, which yields an increase in glucose uptake and the inotropic effects of the heart